Pfizer to acquire Biohaven in $11.6B bet on biotech's migraine …

Pfizer To Acquire Biohaven In $11.6B Bet On Biotech's Migraine …

1 week from now

May 10, 2022  · Dan Kitwood via Getty Images. Pfizer has agreed to acquire Biohaven Pharmaceuticals for $11.6 billion in a deal that turns an existing alliance on a fast-selling …

biopharmadive.com

Pfizer Completes Acquisition Of Biohaven Pharmaceuticals

1 week from now

Oct 3, 2022  · Pfizer acquired all of the outstanding shares of Biohaven not already owned by Pfizer for $148.50 per share in cash, for a total transaction consideration of approximately …

pfizer.com

Pfizer To Buy Biohaven Pharmaceutical In $11.6 Bln Deal

1 week from now

May 10 (Reuters) - Pfizer Inc PFE.N said on Tuesday it will buy migraine drug maker Biohaven Pharmaceutical Holding Company Ltd BHVN.N for about $11.6 billion in cash. Pfizer will …

nasdaq.com

Pfizer Is Acquiring A Migraine Fixer For $11.6 Billion - Nasdaq

1 week from now

May 11, 2022  · The biotech giant announced plans on Tuesday to buy migraine drugmaker Biohaven in an $11.6 billion all-cash deal. It's the kind of mammoth transaction investors have …

nasdaq.com

Two Years After Selling Its Migraine Assets To Pfizer In $13B Deal, …

1 week from now

Oct 28, 2024  · Fast-forward to 2022, when pharmaceutical giant Pfizer Inc. completed its $11.6 billion acquisition of those migraine therapeutic assets, while also paying off Biohaven’s debt, …

hartfordbusiness.com

Pfizer To Acquire Biohaven Pharmaceuticals

1 week from now

of rimegepant and zavegepant outside the United States, in connection with which Pfizer invested $350 million to acquire 2.6% of Biohaven’s common stock at $173 per share. “We are excited …

pfizer.com

Pfizer To Buy Biohaven For $11.6 Billion | C&EN Global Enterprise

1 week from now

May 16, 2022  · Seeking Nurtec, a pill approved to treat and prevent migraine in adults, Pfizer has agreed to acquire its maker, Biohaven Pharmaceuticals, in a cash deal valued at $11.6 billion. …

acs.org

Pfizer Buys Biohaven's Migraine Drugs For $11.6 Billion - PubMed

1 week from now

Pfizer buys Biohaven's migraine drugs for $11.6 billion. Pfizer buys Biohaven's migraine drugs for $11.6 billion Nat Rev Drug Discov. 2022 Jul;21(7):480. doi: 10.1038/d41573-022-00093-3. …

nih.gov

Biohaven Starts Life As New Company Following Pfizer Buyout

1 week from now

Oct 5, 2022  · On Tuesday, Biohaven Ltd. officially launched as a newly independent company, spun out of its former parent as part of Pfizer’s $11.6 billion acquisition, which closed on Oct. …

biopharmadive.com

Biohaven And Pfizer Complete Collaboration Transaction For ...

1 week from now

$150 million cash and $350 million in the purchase of Biohaven equity. At close, Pfizer will own 3% of Biohaven. Biohaven is also eligible to receive up to $740 million in future milestones. In …

pfizer.com